当前位置:首页 - 行情中心 - 明德生物(002932) - 财务分析

明德生物

(002932)

  

流通市值:31.00亿  总市值:46.18亿
流通股本:1.56亿   总股本:2.33亿

明德生物(002932)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.62亿元,每股收益0.35元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益611032.22万元,未分配利润440509.69万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产682994.12万元,负债71961.90万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入225,617,843.38154,270,388.5260,963,422.3749,536,774.56
营业总成本319,893,245.81212,168,994.95104,189,807.01720,146,379.19
营业利润82,281,071.7770,107,733.6234,372,615.18145,194,454.94
利润总额78,074,642.867,715,284.5634,122,219.31139,889,482.45
净利润62,363,772.1654,771,533.9428,108,162.269,216,397.97
其他综合收益----
综合收益总额62,363,772.1654,771,533.9428,108,162.269,216,397.97
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计2,120,880,457.632,384,054,743.912,531,590,450.342,749,924,437.09
非流动资产合计4,709,060,724.794,549,367,260.124,709,247,655.364,636,675,457.11
资产总计6,829,941,182.426,933,422,004.037,240,838,105.77,386,599,894.2
流动负债合计645,171,910.76730,859,846.12858,191,366.71,019,362,336.64
非流动负债合计74,447,114.7573,908,927.0374,746,796.7875,136,094.19
负债合计719,619,025.51804,768,773.15932,938,163.481,094,498,430.83
归属于母公司股东权益合计5,888,448,333.175,898,595,850.246,045,503,355.646,025,889,662
股东权益合计6,110,322,156.916,128,653,230.886,307,899,942.226,292,101,463.37
负债和股东权益合计6,829,941,182.426,933,422,004.037,240,838,105.77,386,599,894.2
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计689,598,336.84487,937,057.78294,315,194.081,898,423,359.01
经营活动现金流出小计812,864,780.68645,892,120.69248,627,111.41,505,925,297.75
经营活动产生的现金流量净额-123,266,443.84-157,955,062.9145,688,082.68392,498,061.26
投资活动现金流入小计423,910,028.25303,251,790.755,491,273.513,954,744,819.8
投资活动现金流出小计568,653,644.73319,328,765.7866,088,150.655,319,810,473.79
投资活动产生的现金流量净额-144,743,616.48-16,076,975.03-60,596,877.14-1,365,065,653.99
筹资活动现金流入小计00058,442,534.28
筹资活动现金流出小计250,643,991.1263,137,043.514,525,250.56728,502,353.18
筹资活动产生的现金流量净额-250,643,991.12-63,137,043.5-14,525,250.56-670,059,818.9
汇率变动对现金及现金等价物的影响-1,049,547.18-63,352.87-376,414.611,262,171.26
现金及现金等价物净增加额-519,703,598.62-237,232,434.31-29,810,459.63-1,641,365,240.37
期末现金及现金等价物余额394,336,276.36676,807,440.67884,229,415.35914,039,874.98
TOP↑